Skip to main content
News Icon

News categories: Honors & Funding

Collaborative research center being renewed

German Research Foundation funds CRC "Synaptic Micronetworks in Health and Disease" for another four years

The mammalian brain is extraordinarily complex - it is estimated to consist of around 100 billion nerve cells. Each of these cells is linked via synapses to tens of thousands of other brain cells. How do the elements of such a complex network work together to produce behavior? How do the networks change as a result of disease? For eight years, scientists have been investigating these and other questions in the Collaborative Research Center (CRC) 1089 "Synaptic Micronetworks in Health and Disease" at the University of Bonn. With great success: The German Research Foundation (DFG) is funding the interdisciplinary network for another four years. The requested funding amount is around 11.1 million euros. Partners are the caesar research center in the Max Planck Society and the German Center for Neurodegenerative Diseases in Bonn. Member of the Cluster of Excellence ImmunoSensation2 Prof. Heinz Beck is spokesperson of the recently renewed CRC.

At the most elementary level, the researchers want to investigate the properties of individual synapses - the contact points between nerve cells. They also want to investigate how these connections between brain cells are affected by diseases in their structure and function. At the next level up, the scientists want to find out how the many tens of thousands of synaptic input signals that arrive at cell processes of the nerve cells, so-called dendrites, are processed. Here, too, the focus is on epilepsy and Alzheimer's disease. At the level of neuronal networks, the researchers are interested in understanding the interplay between different types of nerve cells in the development of normal and pathologically disturbed behavior. To achieve these goals, mathematical and theoretical methods will be increasingly applied in the third funding period.

The researchers in the interdisciplinary CRC 1089 aim to make a significant contribution to a better understanding of how the brain works. However, a particular goal is also to investigate brain dysfunction in two of the most common neurological diseases: Epilepsy and Alzheimer's disease. The speaker of the Collaborative Research Center is the neuroscientist Prof. Dr. Heinz Beck, head of the Institute for Experimental Epileptology and Cognition Research at the University and the University Hospital of Bonn and a member of the ImmunoSensation2 Cluster of Excellence. Vice speaker is the biochemist Prof. Dr. Susanne Schoch McGovern from the Institute of Neuropathology at the University of Bonn.


Contact

Prof. Dr. Heinz Beck

Institute for Experimental Epileptology and Cognitive Research

University of Bonn

University Hospital Bonn

Phone: +49 228 6885270

Email: Heinz.Beck@ukb.uni-bonn.de

Prof. Dr. Susanne Schoch McGovern

Institute of Neuropathology, University of Bonn

University Hospital Bonn

Phone: +49 228 28719109

Email: susanne.schoch@uni-bonn.de

Related news

Prof. Dr. Valentin Schäfer

News categories: Honors & Funding

Valentin Schäfer appointed to Specialized Ethics Committee

Prof. Valentin S. Schäfer, Head of the Section of Rheumatology at the University Hospital Bonn (UKB) and researcher at the University of Bonn, has been appointed to the newly created Specialized Ethics Committee for Special Procedures by State Secretary Dr. Thomas Steffen at the Federal Ministry of Health. The committee, which is based at the Federal Institute for Drugs and Medical Devices (BfArM), will begin its work on July 1, 2025 and is responsible for the ethical evaluation of complex clinical trials.
View entry
Honorary Doctorate Sharon Lewin

News categories: Honors & Funding

Honorary Doctorate awarded to Sharon Lewin

The Faculty of Medicine at the University of Bonn has conferred an honorary doctorate on the illustrious researcher Professor Sharon Lewin. The Director of the Peter Doherty Institute for Infection and Immunity and the Cumming Global Centre for Pandemic Therapeutics, Professor Lewin is also a Laureate Professor of Medicine at the University of Melbourne in Australia and collaborates with the University Hospital Bonn. She is being recognized for her exceptional research on the international stage and her groundbreaking work in the field of HIV research in particular.
View entry
Go-Bio

News categories: Honors & Funding

GO-Bio program supports innovations made in Bonn

Five projects of ImmunoSensation2 members have received funding from the BMBF's GO-Bio initial program to put their innovative research results into practice. The projects are based at the University Hospital Bonn (UKB) and the University of Bonn and will be funded with a maximum of 100,000 euros each in the exploratory phase. The “GO-Bio initial” funding initiative of the Federal Ministry of Education and Research (BMBF) promotes the development of life science research approaches on the way to application.
View entry

Back to the news overview